Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole

International Journal of Antimicrobial Agents

Volumn 39, Issue 6, 2012, Pages 500-504

  Dubreuil, L J ^a   Mahieux, S ^a   Neut, C ^a   Miossec, C ^b   Pace, J ^c  

^a UNIV LILLE   (France)

^b Le Mesnil le Roi ^*  (France)

^c Novexel SA   (France)

Author keywords

Lactams; Anaerobes; Antibiotic susceptibility; NXL104

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AVIBACTAM; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEFTRIAXONE; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

AGAR DILUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; ENTEROBACTERIACEAE; GRAM NEGATIVE ANAEROBIC BACTERIA; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; AZABICYCLO COMPOUNDS; BACTERIA, ANAEROBIC; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; GRAM-NEGATIVE ANAEROBIC BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 84860436685     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.02.013     Document Type: Conference Paper

References (20)

1. L. Dubreuil, J. Breuil, A. Dublanchet, and A. Sedallian Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992 Eur J Clin Microbiol Infect Dis 11 1992 1094 1099 (Pubitemid 23045387)
2. G. Grollier, F. Mory, C. Quentin, F. Girard-Pipau, S. Tigaud, and A. Sedallian Susceptibility of strict anaerobic bacteria to antibiotics in France: a multicenter study Pathol Biol (Paris) 42 1994 498 504 [in French]
3. S. Bland, A. Sedallian, G. Grollier, F. Mory, I. Houcke, and L. Dubreuil In vitro activity of carbapenems (biapenem, imipenem and meropenem) and some other antibiotics against strict anaerobic bacteria Pathol Biol (Paris) 43 1995 289 293 [in French]
4. F. Mory, A. Lozniewski, S. Bland, A. Sedallian, G. Grollier, and F. Girard-Pipau Survey of anaerobic susceptibility patterns: a French multicentre study Int J Antimicrob Agents 10 1998 229 236 (Pubitemid 28432056)
5. J. Behra-Miellet, L. Calvet, F. Mory, C. Muller, M. Chomarat, and M.C. Bézian Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric survey Anaerobe 9 2003 105 111 (Pubitemid 36970207)
6. A. Liebetrau, A.C. Rodloff, J. Behra-Miellet, and L. Dubreuil In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria Antimicrob Agents Chemother 47 2003 3667 3671 (Pubitemid 37345746)
7. L.M. Koeth, C.E. Good, P.C. Appelbaum, E.J. Goldstein, A.C. Rodloff, and M. Claros Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents J Antimicrob Chemother 53 2004 1039 1044 (Pubitemid 38807646)
8. J. Behra-Miellet, L. Dubreuil, and L. Calvet Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria Int J Antimicrob Agents 28 2006 25 35
9. J. Brazier, D. Chmelar, L. Dubreuil, G. Feierl, M. Hedberg, and S. Kalenic European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci Int J Antimicrob Agents 31 2008 316 320
10. E. Singer, L. Calvet, F. Mory, C. Muller, M. Chomarat, and M.C. Bézian Monitoring of antibiotic resistance of Gram negative anaerobes Med Mal Infect 38 2008 256 263 [in French]
11. E. Nagy, E. Urbán, C.E. Nord ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience Clin Microbiol Infect 17 2011 371 379
12. L. Dubreuil, and M.F. Odou Anaerobic bacteria and antibiotics: what kind of unexpected resistance could I find in my laboratory tomorrow? Anaerobe 16 2010 555 559
13. Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard. 7th ed. Document M11-A7. Wayne, PA: CLSI; 2007.
14. D.M. Citron, and E.J.C. Goldstein In vitro activity of NXL104/ceftazidime against β lactamase producing anaerobic bacteria 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICCAC) 12-15 September 2009, San Francisco, CA 2009 ASM Press Washington, DC [Abstract E 192]
15. A. Endimiani, Y. Choudhary, and R.A. Bonomo In vitro activity of NXL104 in combination with β-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases Antimicrob Agents Chemother 53 2009 3599 3601
16. A. Endimiani, K.M. Hujer, A.M. Hujer, M.E. Pulse, W.J. Weiss, and R.A. Bonomo Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae Antimicrob Agents Chemother 55 2011 82 85
17. P.R.S. Lagacé-Wiens, F. Tailor, P. Simner, M. DeCorby, J.A. Karlowsky, and A. Walkty Activity of NXL104 in combination with β-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum β-lactamases and class C β-lactamases Antimicrob Agents Chemother 55 2011 2434 2437
18. D.M. Livermore, S. Mushtaq, M. Warner, J. Zhang, S. Maharjan, and M.M. Doumith Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae Antimicrob Agents Chemother 55 2011 390 394
19. B.A. Rasmussen, Y. Gluzman, and F.P. Tally Cloning and sequencing of the class B β-lactamase gene (ccrA) from Bacteroides fragilis TAL3636 Antimicrob Agents Chemother 34 1990 1590 1592 (Pubitemid 20257614)
20. M.F. Odou, E. Singer, M.B. Romond, and L. Dubreuil Isolation and characterization of a porin-like protein of 45 kilodaltons from Bacteroides fragilis FEMS Microbiol Lett 166 1998 347 354 (Pubitemid 128384181)